Multiple Ascending Dose Study of MHS552 in Adults Participants With Systemic Lupus Erythematosus (SLE)

NCT05203419 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Lupus Erythematosus, Systemic

Interventions

DRUG: MHS552
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals